Guidelines: Finnish Medical Association Duodecim Guidelines (Finland)

From Beacon
Revision as of 12:26, 6 November 2023 by Francine (talk | contribs) (Created page with "{{#subobject:Finnish Medical Association Duodecim Guidelines |dct:title=Finnish Medical Association Duodecim Guidelines |datatype=guideline }} '''Sponsor, manager or home institution:''' Duodecim of the Finnish Medical Society and other institutions. '''Primary purpose:''' To provide independent national treatment recommendations based on research evidence. '''Type of information:''' Treatment recommendations; Epidemiology and etiology; Prevalence classification and...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


Sponsor, manager or home institution: Duodecim of the Finnish Medical Society and other institutions.

Primary purpose: To provide independent national treatment recommendations based on research evidence.

Type of information: Treatment recommendations; Epidemiology and etiology; Prevalence classification and histological classification; Diagnostics; Monitoring; Quality of life of patients of prostate, lung, oral cancer and palliative care and hospice care recommendations.

Access to information: List of guidelines [1].